1. Home
  2. SACH vs NOTV Comparison

SACH vs NOTV Comparison

Compare SACH & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

N/A

Current Price

$1.10

Market Cap

48.6M

Sector

Real Estate

ML Signal

N/A

Logo Inotiv Inc.

NOTV

Inotiv Inc.

N/A

Current Price

$0.39

Market Cap

12.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SACH
NOTV
Founded
2010
1974
Country
United States
United States
Employees
29
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.6M
12.7M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
SACH
NOTV
Price
$1.10
$0.39
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$2.00
$1.50
AVG Volume (30 Days)
119.3K
575.0K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
18.35%
N/A
EPS Growth
N/A
49.64
EPS
N/A
N/A
Revenue
N/A
$547,656,000.00
Revenue This Year
N/A
$5.28
Revenue Next Year
$1.17
$5.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
511.19
52 Week Low
$0.80
$0.25
52 Week High
$1.35
$3.35

Technical Indicators

Market Signals
Indicator
SACH
NOTV
Relative Strength Index (RSI) 69.13 53.23
Support Level $1.04 $0.26
Resistance Level $1.13 $0.65
Average True Range (ATR) 0.03 0.05
MACD 0.01 0.03
Stochastic Oscillator 80.51 70.04

Price Performance

Historical Comparison
SACH
NOTV

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: